Skip to main content
Caplight Logo









Allergy Amulet

Allergy Amulet

Private
Madison, WisconsinHealthcare & Life Scienceshttps://www.allergyamulet.com/

Last Round

Series A

Aug 12, 2024

Total Funding Raised

$14.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Allergy Amulet is a health technology company that provides a portable sensor for consumers and businesses to detect food allergens in seconds.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sensors, Health IoT

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

allergen detectionfood safetywearable sensorfood allergyelectrochemical sensorfood techmolecular detectiondisposable test stripsallergy trackerhealth iotmedical devicerazor and bladesmolecularly imprinted polymerMIP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Allergy Amulet Comparables

Compare Allergy Amulet with similar companies based on industry and business-model similarity.

Allergy Amulet comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LEO Verification Systems
83%
Glutensens
78%
NIMA Partners
77%

Allergy Amulet Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 12, 2024
GrantJan 21, 2022
SeedMar 29, 2021
SeedAug 12, 2020
SeedNov 15, 2016

Key People

Founding team and executive leadership

Abigail Barnes

Founder & CEO

Founding Team

Allergy Amulet Investors

Notable investors and investment history

Allergy Amulet investors
InvestorRounds
Great Oaks Venture CapitalSeries A, Seed
AllerFundSeries A, Seed
gener8torSeed
HealthX VenturesSeries A
Colle CapitalSeed
Dipalo VenturesSeed
Bulldog Innovation GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors grew 340% MoM.

  • Jan 21, 2022

    Received grant funding from the National Science Foundation.

Allergy Amulet Filings

Explore SEC and related filing metadata, where available.

Allergy Amulet filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Allergy Amulet's valuation, stock price, and market status.

Is Allergy Amulet a public or private company?

Allergy Amulet is a private company.

What is the current stock price of Allergy Amulet?

Allergy Amulet is a private company with no public stock price. No recent secondary market data is available.

How much is Allergy Amulet worth (valuation)?

Valuation information for Allergy Amulet is not publicly available.

Can I buy Allergy Amulet stock?

Allergy Amulet shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Allergy Amulet's last funding round?

Allergy Amulet's most recent funding round was Series A on August 12, 2024.

Who are the main investors in Allergy Amulet?

Key investors in Allergy Amulet include AllerFund, HealthX Ventures, TitletownTech.

Will Allergy Amulet IPO soon?

No public IPO plans have been announced for Allergy Amulet.

How can I track Allergy Amulet secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Allergy Amulet's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMadison, Wisconsin
Employee Range16
Year Founded2016
Last FundingAug 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?